We’ve Got Your BAK

Imagine a world where you could use as much preservative as you needed in a prescription eye drop without ever having to worry it would reach the cornea? Well, that’s exactly what TearClear is doing in an attempt to get a slice of the $3.7 billion glaucoma medication market. TearClear aims to be the premier … Continue reading We’ve Got Your BAK